Skip to content

Author

David Abraham Batista da Hora

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Nov 2026

Remimazolam versus propofol for sedation in mechanically ventilated ICU patients: A systematic review and meta-analysis of randomized controlled trials.

BACKGROUND Propofol is widely used for sedation in the intensive care unit (ICU), but its use may be limited by cardiovascular depression, hypertriglyceridemia, and propofol infusion syndrome. Remimazolam has emerged as a potential alternative to propofol, with rapid metabolism, predictable recovery, and flumazenil rev...

Shunichi Nakahara, A. Velarde Pineda, C. A. Romero Bonifaz et al. · 0 citations
Review Oct 2026

Impact of High-Dose Influenza Vaccine on Cardiorespiratory Outcomes in Older Adults: An Updated Systematic Review and Meta-Analysis.

INTRODUCTION Older adults face an increased risk of influenza-related complications, particularly cardiovascular (CV) events. The comparative effectiveness of high-dose inactivated influenza vaccine (HD-IIV) versus standard-dose inactivated influenza vaccine (SD-IIV) for these outcomes remains uncertain. METHODS Data...

Larissa Araújo de Lucena, B. Hakkeem, N. Schettino Samad et al. · 0 citations
Review Sep 2026

Remimazolam versus sevoflurane for general anaesthesia: A meta-analysis with trial sequential analysis of haemodynamic and clinical outcomes.

BACKGROUND Remimazolam is a novel ultra-short-acting intravenous benzodiazepine, while sevoflurane is a widely used inhalational anaesthetic for general anaesthesia (GA). Both agents are associated with risks of haemodynamic instability and postoperative nausea and vomiting (PONV), which can affect patient safety and r...

L. Takayama, Kevlin de Souza, David Abraham Batista da Hora et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.